RAPT Therapeutics
IPO
Relentlessly focused on advancing treatments for patients with inflammatory and immunologic diseases
- Headquarters
- San Francisco, California
- Employees
- 51–200
- Founded
- 2015
- Business Model
- B2B
- Website
- rapt.com
- Total Funding
- $497.0M
- Last Round
- $250.0M Private EquityOct 2025
About
RAPT Therapeutics is a clinical-stage biopharmaceutical company focused on discovering, developing, and commercializing oral small molecule therapeutics that target key drivers of the immune system for inflammatory and immunologic diseases, including food allergy.
Sign up to view funding chart
Create a free account to see funding visualizations and detailed round data.
Create Free AccountFunding History
Sign up to view funding details
Create a free account to see full funding history, valuations, and investor participation.
Create Free Account